AI assistant
REPLIGEN CORP — Director's Dealing 2024
Jun 15, 2024
30826_dirs_2024-06-14_59367a2d-03ec-4da2-8ea9-418377f7c46f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: REPLIGEN CORP (RGEN)
CIK: 0000730272
Period of Report: 2024-06-14
Reporting Person: Madaus Martin D (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-06-14 | Common Stock | P | 915 | $124.54 | Acquired | 3913 | Direct |
| 2024-06-14 | Common Stock | P | 700 | $125.46 | Acquired | 4613 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 11 | Indirect |
Footnotes
F1: $124.54 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $124.25 to $125.21, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate purchase price within the range.
F2: $125.46 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $125.25 to $125.58, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate purchase price within the range.
F3: Held by a trust for which the Reporting Person is a trust advisor who shares voting and investment control.